A Study to Learn If a Booster Dose of BNT162b2 Was Safe and Effective in Healthy Children and Adults
Substudy A Final Report: A Phase 3 Master Protocol to Evaluate Additional Dose(s) of BNT162b2 in Healthy Individuals Previously Vaccinated With BNT162b2
Category & Conditions: Vaccine-related Conditions
Medicine: PF-07302048 (BNT162)
ClinicalTrials.gov Identifier (NCT): NCT04955626
Protocol ID: C4591031 SSA
PrintDownloadOpen Plain Language Summary Result: Click here